Maze Therapeutics Announces $150 Million Registered Offering
Summary
SOUTH SAN FRANCISCO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE) today announced the pricing of its underwritten registere...
Description
SOUTH SAN FRANCISCO, Calif., April 22, 2026 (GLOBE NEWSWIRE) -- Maze Therapeutics, Inc. (Nasdaq: MAZE) today announced the pricing of its underwritten registere...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source